Gene · 10890
Papers1,621
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,621
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intracellular Localization of PD-L1 in Rab10-positive Open Tubular Endosome System of Cancer Cells. | Acta Histochem Cytochem | 2026 | 41810323 | PubTator, text mining | PubMed |
| LRRK2 kinase mediates increased GCase activity in microglia in response to IFNγ-induced proinflammatory stimulation. | NPJ Parkinsons Dis | 2026 | 41786767 | PubTator, text mining | PubMed |
| Role of LRRK2 in physiological activities, diseases, and therapy. | Chin Med J (Engl) | 2026 | 41782203 | PubTator, text mining | PubMed |
| CSF LRRK2: A biomarker for slower autonomic dysfunction progression in sporadic Parkinson's disease. | Auton Neurosci | 2026 | 41762849 | PubTator, text mining | PubMed |
| An Exploratory Biomarker Study of First-Trimester Circulating miRNAs Associated with Later Gestational Diabetes Mellitus. | Int J Mol Sci | 2026 | 41752058 | PubTator, text mining | PubMed |
| Pathophysiological Roles of Two Intracellular P-Type ATPases: The Cancer-Associated Na+,K+-ATPase α3 Isoform and the Parkinson's Disease-Related ATP13A2. | Int J Mol Sci | 2026 | 41751935 | PubTator, text mining | PubMed |
| The Evolution, Oligomerization, Function, and Action Mechanism of α2-Macroglobulin. | Cells | 2026 | 41744796 | PubTator, text mining | PubMed |
| Membrane Dysfunction as a Central Mechanism in LRRK2-Associated Parkinson's Disease: Comparative Analysis of G2019S and I1371V Variants. | Cells | 2026 | 41744785 | PubTator, text mining | PubMed |
| CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability. | J Pharm Anal | 2026 | 41732321 | PubTator, text mining | PubMed |
| The dual role of autophagy in cartilage degradation: from mechanisms to targeted therapeutics. | Front Cell Dev Biol | 2026 | 41716288 | PubTator, text mining | PubMed |
| Role and underlying mechanisms of miR‑200 family in breast cancer (Review). | Int J Oncol | 2026 | 41716019 | PubTator, text mining | PubMed |
| TBK1 activity regulates the directionality of axonal transport of signalling endosomes. | Life Sci Alliance | 2026 | 41638908 | PubTator, text mining | PubMed |
| Exosome RAB10 inhibits JAK1/STAT1 to hinder macrophage M1 polarization and promote tumor immune escape. | Cell Commun Signal | 2026 | 41588435 | PubTator, text mining | PubMed |
| Migrasome and cancer - from cellular to clinical perspectives. | Biomark Res | 2026 | 41545844 | PubTator, text mining | PubMed |
| RAB10 mediates metabolic regulation of ferroptosis in breast Cancer and synergistically remodels the tumour immune microenvironment via macrophage M2 polarization. | Int Immunopharmacol | 2026 | 41544532 | PubTator, text mining | PubMed |
| Structural basis for binding of RILPL1 to TMEM55B reveals a lysosomal platform for adaptor assembly through a conserved peptide motif. | Structure | 2026 | 41314214 | PubTator, text mining | PubMed |
| Identification of lymphangiogenesis-related diagnostic model for predicting abdominal aortic aneurysm onset and progression and validation of lymphopoiesis in abdominal aortic aneurysm. | Mol Cell Probes | 2026 | 41183720 | PubTator, text mining | PubMed |
| VPS35 mutation inhibits PINK1/parkin-mediated mitophagy via increased LRRK2 kinase activity. | Brain | 2026 | 41164908 | PubTator, text mining | PubMed |
| Emerging roles of the ciliary-mitochondrial axis in cellular homeostasis and neuroprotection. | Mol Neurodegener Adv | 2025 | 42751568 | PubTator, text mining | PubMed |
| Parkinson's disease LRRK2 mutations dysregulate iron homeostasis and promote oxidative stress and ferroptosis in human neurons and astrocytes. | bioRxiv | 2025 | 41542458 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10890/papers?page=2